Human renal cell adenocarcinoma cells (ACHN-EGFP)

The applications of Human renal cell adenocarcinoma cells (ACHN-EGFP) are pivotal in cancer research as these cells serve as a valuable model for studying renal cancer biology and the efficacy of novel therapeutic agents By utilizing these epithelial adherent cells researchers can investigate the underlying mechanisms of tumor progression and metastasis while also screening potential drug candidates to find effective treatments for renal cell carcinoma

In addition the ability to transport and preserve ACHN-EGFP cells using dry ice ensures that they remain viable for experimentation facilitating collaboration between laboratories and contributing to a wider range of studies in cellular responses to therapies The combination of these cells with the appropriate growth conditions such as 90% DMEM supplemented with 10% FBS allows researchers to maintain the physiological relevance of their experiments ultimately enhancing the translational potential of their findings

Moreover the incorporation of the EGFP (enhanced green fluorescent protein) marker in ACHN cells allows for real-time visualization and tracking of cancer cell behavior and interactions providing insights that are critical for developing targeted therapies and understanding tumor microenvironments This innovative approach not only aids in advancing the field of oncology but also fosters the discovery of biomarkers that could lead to breakthroughs in personalized medicine